Infectious Disease Molecular Diagnostics Market is Anticipated to Grow US$ 50.8 Bn By 2030

The global Infectious Disease Molecular Diagnostics market size is expected to reach USD 50.8 billion by 2030 and is expected to expand at a CAGR of 10.0% from 2021 to 2030. 

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38475

Growth Factors

The market is driven by the introduction of technologically advanced products and an increase in demand for in PoC settings. Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies. 

Report Highlights

The reagents segment dominated the market for infectious disease molecular diagnostics and accounted for the largest revenue share of 76.7% in 2020 attributable to the introduction and commercialization of new reagents and the high uptake rate when compared to instruments. Novel reagent launches have risen exponentially due to increased demand for PCR reagents.

The PCR segment dominated the market for infectious disease molecular diagnostics and accounted for the largest revenue share of 95.4% in 2020. This growth can be attributed to its conventional use in the diagnosis of infectious diseases and advancements in the technology to detect novel infectious diseases.  Increasing use of high-throughput PCR technology to detect coronavirus is expected to drive segment growth.

The Human Papillomavirus (HPV) segment is projected to witness a lucrative CAGR of 17.9% over the forecast period. This is attributable to the increased incidence rate of the disease.

The diagnostic laboratories segment dominated the market for infectious disease molecular diagnostics and accounted for the largest revenue share of 86.4% in 2020 owing to high procedure volumes and market penetration. The rising number of initiatives undertaken by the government for the provision of various services, such as diagnostic test reimbursements, is another major factor anticipated to drive the market for infectious disease molecular diagnostics.

North America dominated the market for infectious disease molecular diagnostics and accounted for the largest revenue share of 44.9% in 2020. This is attributed to growing regulatory support and increasing investment in diagnostics is anticipated to fuel growth.

Key Players

  • Abbott
  • Danaher Corporation
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc. (Gen-Probe)
  • Illumina, Inc.
  • Grifols S.A.
  • Qiagen
  • Siemens Healthineers AG
  • Sysmex Corporation
Report Coverage Details
Market Size US$ 50.8 billion by 2030
Growth Rate CAGR of 10.0% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, End-use, Technology, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Abbott; Becton, Dickinson and Company; bioMérieux SA; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Danaher Corporation; Hologic, Inc. (Gen-Probe); Illumina, Inc.; Grifols S.A.; Qiagen; F. Hoffmann-La Roche Ltd, Siemens Healthineers AG; Sysmex Corporation

Market Segmentation

  • Product
    • Instruments
    • Reagents
    • Services
  • End-use
    • Hospitals
    • Clinics
    • Diagnostics Laboratories
    • Research Institutes
  • Technology
    • Polymerase chain reaction (PCR)
      • PCR, by Type
        • Multiplex PCR
        • Other PCR
      • PCR, by Product
        • Instruments
        • Reagents
        • Services
    • In Situ Hybridization
      • Instruments
      • Reagents
      • Services
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Instruments
      • Reagents
      • Services
    • Chips and Microarrays
      • Instruments
      • Reagents
      • Services
    • Mass Spectrometry
      • Instruments
      • Reagents
      • Services
    • Sequencing
      • Instruments
      • Reagents
      • Services
    • Transcription Mediated Amplification
      • Instruments
      • Reagents
      • Services
    • Others
      • Instruments
      • Reagents
      • Services
  • Application
    • Respiratory Diseases
    • Tuberculosis
    • Meningitis
    • Gastrointestinal Tract Infections
    • HPV
    • Sexually Transmitted Infections
    • Sepsis
    • Drug Resistance Diseases
    • Other Infectious Diseases

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38475

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw End-use Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Infectious Disease Molecular Diagnostics Market, By Product

7.1.  Infectious Disease Molecular Diagnostics Market, by Product, 2021-2030

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Reagents

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Infectious Disease Molecular Diagnostics Market, By End-use

8.1.  Infectious Disease Molecular Diagnostics Market, by End-use, 2021-2030

8.1.1.    Hospitals

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Clinics

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Diagnostics Laboratories

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Research Institutes

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Infectious Disease Molecular Diagnostics Market, By Technology

9.1.  Infectious Disease Molecular Diagnostics Market, by Technology, 2021-2030

9.1.1.    Polymerase chain reaction (PCR)

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    In Situ Hybridization

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Isothermal Nucleic Acid Amplification Technology (INAAT)

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Chips and Microarrays

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Mass Spectrometry

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Sequencing

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Transcription Mediated Amplification

9.1.7.1.        Market Revenue and Forecast (2017-2030)

9.1.8.    Others

9.1.8.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Infectious Disease Molecular Diagnostics Market, By Application

10.1.        Infectious Disease Molecular Diagnostics Market, by Application, 2021-2030

10.1.1.  Respiratory Diseases

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Tuberculosis

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Meningitis

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Gastrointestinal Tract Infections

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  HPV

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Sexually Transmitted Infections

10.1.6.1.      Market Revenue and Forecast (2017-2030)

10.1.7.  Sepsis

10.1.7.1.      Market Revenue and Forecast (2017-2030)

10.1.8.  Drug Resistance Diseases

10.1.8.1.      Market Revenue and Forecast (2017-2030)

10.1.9.  Other Infectious Diseases

10.1.9.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Infectious Disease Molecular Diagnostics Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.4.  Market Revenue and Forecast, by Application (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.4.  Market Revenue and Forecast, by Application (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.4.  Market Revenue and Forecast, by Application (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.4.  Market Revenue and Forecast, by Application (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by Application (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.4.  Market Revenue and Forecast, by Application (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by Application (2017-2030)

Chapter 12.  Company Profiles

12.1.              Abbott

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Danaher Corporation

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              bioMérieux SA

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              F. Hoffmann-La Roche Ltd

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bio-Rad Laboratories, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Agilent Technologies, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Becton, Dickinson and Company

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Hologic, Inc. (Gen-Probe)

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Illumina, Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Grifols S.A.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Qiagen

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Siemens Healthineers AG

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Sysmex Corporation

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38475

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com